External and Implantable Cardiac Defibrillators Market is set for steady growth to US$ 12.16 billion by 2033, led by North America 42% of global market share.

The Global External and Implantable Cardiac Defibrillators Market reached US$ 6.58 billion in 2024 and is expected to reach US$ 12.16 billion by 2033, growing at a CAGR of 7.1% during the forecast period 2025-2033.

Market growth is driven by the rising incidence of cardiovascular diseases and sudden cardiac arrest, increasing adoption of implantable cardioverter defibrillators (ICDs) and external defibrillators for both hospital and homecare settings, and growing emphasis on early intervention and emergency cardiac care. Additionally, advancements in device miniaturization, battery longevity, and remote monitoring technologies, expanding use in post-myocardial infarction and high-risk patient management, and favorable reimbursement policies and public access defibrillation programs are further supporting market expansion.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):-https://www.datamintelligence.com/download-sample/external-and-implantable-cardiac-defibrillators-market?pratik

United States: Key Industry Developments
✅ December 2025: Medtronic expanded its external defibrillator portfolio with FDA approval for the next-generation Empower ICD, featuring miniaturized design and AI-enhanced shock delivery, reducing procedure time by 25% for high-risk sudden cardiac arrest patients.
​
✅ October 2025: Boston Scientific launched the EMBLEM S-ICD with upgraded Subcutaneous Electrode System in the U.S., improving leadless implantation accuracy and MRI compatibility for younger patients with fewer comorbidities.
​
✅ August 2025: ZOLL Medical Corporation introduced the X Series advanced external defibrillator with wireless data integration, enhancing EMS response times and remote monitoring amid rising out-of-hospital cardiac events.
​
Asia Pacific / Japan: Key Industry Developments
✅ November 2025: Medtronic Japan launched the Aurora EV-ICD MRI-compatible implantable defibrillator, supporting extravascular leads for ventricular tachycardia treatment and enabling full-body MRI scans post-implant.
​
✅ September 2025: Abbott received Japanese PMDA approval for the Gallant ICD with Bluetooth connectivity, allowing patient apps for remote alerts and reducing clinic visits by 40% in aging populations.
​
✅ July 2025: Nihon Kohden collaborated with local hospitals to deploy next-gen automated external defibrillators (AEDs) with voice-guided bilingual interfaces, boosting public access deployment in urban areas amid CVD prevalence rise.

Recent M&A Activity:-
Bridgepoint - Safe Life (June 12, 2025)
✅ Bridgepoint Group solidified its position in the emergency cardiac response sector by acquiring a controlling stake in Safe Life, a global leader in defibrillator distribution and AED solutions, enhancing access to life-saving devices through expanded international reach, training programs, and aftermarket services amid rising public awareness of sudden cardiac arrest.
​
Defibrion (IK Partners) - Ecosafety (August 5, 2025)
✅ Defibrion, backed by IK Partners, expanded its emergency response portfolio in the defibrillator and safety equipment market through the acquisition of Ecosafety, a key Dutch distributor of fire safety products, streamlining supplier networks and bolstering offerings for cardiac emergency preparedness in public and commercial settings.
​
Teleflex - Biotronik's Vascular Intervention Unit (Completed July 1, 2025)
✅ Teleflex strengthened its interventional cardiology capabilities, indirectly supporting cardiac defibrillator ecosystems, by completing the €760 million acquisition of Biotronik's Vascular Intervention business on July 1, 2025 (announced February 27, 2025), adding coronary and peripheral vascular devices to enhance cath lab presence and procedural outcomes for arrhythmia patients

Market Segmentation Analysis:
-By Product Type: Implantable vs External
Implantable cardioverter defibrillators hold around 52% market share in 2024, driven by rising cardiovascular disorders and demand for long-term monitoring in high-risk patients.
​External defibrillators account for the remaining 48%, popular for acute settings like hospitals due to ease of use and temporary applications.
​
-By Patient Type: Adult vs Pediatric
Adult patients dominate with the largest share in 2024, reflecting higher cardiovascular disease prevalence and aging populations needing ICD implants.
​Pediatric segments remain smaller, focused on congenital conditions, with limited but growing adoption of specialized smaller devices.
​
-By End-User: Hospitals vs Others
Hospitals lead with approximately 79.3% share in 2024, as primary sites for implantation and professional defibrillation.
​Other end-users like home care and clinics hold the rest, boosted by telehealth and portable device trends

📌 Buy Now & Unlock 360° Market Intelligence:https://www.datamintelligence.com/buy-now-page?report=external-and-implantable-cardiac-defibrillators-market?pratik

Growth Drivers:-
Market growth is driven by the rising prevalence of cardiovascular diseases and sudden cardiac arrest cases worldwide.

Increasing adoption of implantable cardioverter defibrillators (ICDs) due to proven effectiveness in preventing cardiac deaths.

Growing awareness and deployment of automated external defibrillators (AEDs) in public and healthcare settings.

Technological advancements such as remote monitoring, miniaturization, and improved battery life.

Favorable reimbursement policies and supportive government initiatives for cardiac care.

Regional Insights:
North America commands the largest share of the External and Implantable Cardiac Defibrillators Market, estimated at around 42% in recent assessments, driven by advanced healthcare infrastructure, high cardiovascular disease prevalence, substantial R&D investments, and favorable reimbursement policies in the US and Canada.
​
Europe follows as the second-largest region, benefiting from established medical device regulations, rising adoption in countries like Germany, France, and the UK, and growing awareness of sudden cardiac arrest management, though exact shares vary by report amid steady market expansion.
​
Asia Pacific ranks third in market share, yet exhibits the fastest growth potential with high CAGRs in nations such as China, India, and Japan, fueled by increasing healthcare investments, government subsidies for medical devices, and expanding geriatric populations.

Speak to Our Analyst and Get Customization in the report as per your requirements:https://www.datamintelligence.com/customize/external-and-implantable-cardiac-defibrillators-market?pratik

Key Players:
The major global players in the external and implantable cardiac defibrillators market include Koninklijke Philips N.V., Nihon Kohden Corporation, Medtronic plc, Boston Scientific Corporation, Stryker Corporation, ZOLL Medical Corporation, Abbott Laboratories, MicroPort Medical Products Ltd., LivaNova PLC, Mindray Medical India Pvt. Ltd. and among others.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?pratik

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele

This release was published on openPR.